_id
6911be5cccc777a4e85d62bb
Ticker
GNPX
Name
Genprex Inc
Exchange
NASDAQ
Address
3300 Bee Cave Road, Austin, TX, United States, 78746
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.genprex.com
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC. Its three-lung cancer clinical programs have received a Fast Track Designation from the FDA for the treatment of that patient population, and SCLC program has received an FDA Orphan Drug Designation. The company's diabetes gene therapy comprises of a novel infusion process that uses an AAV vector to deliver Pdx1 and MafA genes directly to the pancreas. In models of Type 1 diabetes, its GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which produce insulin but distinct enough from beta cells to evade the body's immune system; and GPX-002 for Type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. It has research agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive. Genprex, Inc. was incorporated in 2009 and is based in Austin, Texas.
Last Close
2.58
Volume
55667
Current Price
2.3951
Change
-7.1666666666666785
Last Updated
2025-11-30T19:29:30.037Z
Image
data:image/webp;base64,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
Ipo Date
2018-03-29T00:00:00.000Z
Market Cap
6755821
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
5
Target Price
7.5
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
3345913
Operating Income
-3345913
Interest Expense
455549
Pretax Income
-3799240
Net Income
-3799240
Eps
-4.99570020854646
Dividends Per Share
-
Shares Outstanding
1631841
Income Tax Expense
-
EBITDA
-3799238
Operating Margin
-
Total Other Income Expense Net
-453327
Cash
1103315
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
1715101
Property Plant Equipment
-
Total Assets
3562513
Payables
1619446
Short Term Debt
-
Long Term Debt
-
Total Liabilities
2794706
Equity
767807
Depreciation
0
Change In Working Capital
136859
Cash From Operations
-3187278
Capital Expenditures
2
Cash From Investing
-
Cash From Financing
2943749
Net Change In Cash
-243529
PE
0.0974
PB
2.372312755939969
ROE
-494.81705689059885
ROA
-106.6449441728353
FCF
-3187280
Fcf Percent
-
Piotroski FScore
1
Health Score
25
Deep Value Investing Score
4.5
Defensive Investing Score
4
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
1
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
3345913
Quarters > 0 > income Statement > operating Income
-3345913
Quarters > 0 > income Statement > interest Expense
455549
Quarters > 0 > income Statement > pretax Income
-3799240
Quarters > 0 > income Statement > net Income
-3799240
Quarters > 0 > income Statement > eps
-4.99570020854646
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
760502
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-3799238
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-453327
Quarters > 0 > balance Sheet > cash
1103315
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1715101
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
3562513
Quarters > 0 > balance Sheet > payables
1619446
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2794706
Quarters > 0 > balance Sheet > equity
767807
Quarters > 0 > cash Flow > net Income
-3799240
Quarters > 0 > cash Flow > depreciation
0
Quarters > 0 > cash Flow > change In Working Capital
136859
Quarters > 0 > cash Flow > cash From Operations
-3187278
Quarters > 0 > cash Flow > capital Expenditures
2
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
2943749
Quarters > 0 > cash Flow > net Change In Cash
-243529
Quarters > 0 > ratios > PE
-4.99570020854646
Quarters > 0 > ratios > PB
2.372312755939969
Quarters > 0 > ratios > ROE
-494.81705689059885
Quarters > 0 > ratios > ROA
-106.6449441728353
Quarters > 0 > ratios > FCF
-3187280
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
25
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
4681784
Quarters > 1 > income Statement > operating Income
-4681784
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-4674901
Quarters > 1 > income Statement > net Income
-4674901
Quarters > 1 > income Statement > eps
-8.470880392259897
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
551879
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4681784
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
6883
Quarters > 1 > balance Sheet > cash
1346844
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
2056184
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
3827524
Quarters > 1 > balance Sheet > payables
930812
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2436329
Quarters > 1 > balance Sheet > equity
1391195
Quarters > 1 > cash Flow > net Income
-4674902
Quarters > 1 > cash Flow > depreciation
0
Quarters > 1 > cash Flow > change In Working Capital
355166
Quarters > 1 > cash Flow > cash From Operations
-3864235
Quarters > 1 > cash Flow > capital Expenditures
5
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
1742741
Quarters > 1 > cash Flow > net Change In Cash
-2121494
Quarters > 1 > ratios > PE
-8.470880392259897
Quarters > 1 > ratios > PB
0.9501222998213765
Quarters > 1 > ratios > ROE
-336.03491961946384
Quarters > 1 > ratios > ROA
-122.13903818761163
Quarters > 1 > ratios > FCF
-3864240
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
32
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
9916
Quarters > 2 > income Statement > cost Of Revenue
463
Quarters > 2 > income Statement > gross Profit
-463
Quarters > 2 > income Statement > operating Expenses
3969292
Quarters > 2 > income Statement > operating Income
-3969292
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-3964601
Quarters > 2 > income Statement > net Income
-3964601
Quarters > 2 > income Statement > eps
-12.985706097181508
Quarters > 2 > income Statement > dividends Per Share
277119000
Quarters > 2 > income Statement > shares Outstanding
305305
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-3967619
Quarters > 2 > income Statement > operating Margin
-40029.164985881405
Quarters > 2 > income Statement > total Other Income Expense Net
4691
Quarters > 2 > balance Sheet > cash
3468338
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
4163739
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
6009687
Quarters > 2 > balance Sheet > payables
1525684
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2141832
Quarters > 2 > balance Sheet > equity
3867855
Quarters > 2 > cash Flow > net Income
-3964601
Quarters > 2 > cash Flow > depreciation
463
Quarters > 2 > cash Flow > change In Working Capital
-381022
Quarters > 2 > cash Flow > cash From Operations
-4161425
Quarters > 2 > cash Flow > capital Expenditures
5
Quarters > 2 > cash Flow > cash From Investing
-1
Quarters > 2 > cash Flow > cash From Financing
6028103
Quarters > 2 > cash Flow > net Change In Cash
1866678
Quarters > 2 > ratios > PE
-12.985706097181508
Quarters > 2 > ratios > PB
0.1890546583312973
Quarters > 2 > ratios > ROE
-102.50128301086778
Quarters > 2 > ratios > ROA
-65.97017448662467
Quarters > 2 > ratios > FCF
-4161430
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-419.6682129891085
Quarters > 2 > health Score
29
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
4335730
Quarters > 3 > income Statement > operating Income
-4335730
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-4330462
Quarters > 3 > income Statement > net Income
-4330462
Quarters > 3 > income Statement > eps
-0.3987293584042583
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
10860655
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
545
Quarters > 3 > balance Sheet > cash
1601660
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2077467
Quarters > 3 > balance Sheet > property Plant Equipment
0
Quarters > 3 > balance Sheet > total Assets
4124325
Quarters > 3 > balance Sheet > payables
1074295
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2504170
Quarters > 3 > balance Sheet > equity
1620155
Quarters > 3 > cash Flow > net Income
-4607580
Quarters > 3 > cash Flow > depreciation
463
Quarters > 3 > cash Flow > change In Working Capital
157732
Quarters > 3 > cash Flow > cash From Operations
-3869430
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
3982810
Quarters > 3 > cash Flow > net Change In Cash
113379
Quarters > 3 > ratios > PE
-0.3987293584042583
Quarters > 3 > ratios > PB
16.055472958142893
Quarters > 3 > ratios > ROE
-267.28689538963863
Quarters > 3 > ratios > ROA
-104.99807847344718
Quarters > 3 > ratios > FCF
-3869430
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
25
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
6693
Annuals > 0 > income Statement > gross Profit
-6693
Annuals > 0 > income Statement > operating Expenses
21167474
Annuals > 0 > income Statement > operating Income
-21174167
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-21111163
Annuals > 0 > income Statement > net Income
-21111163
Annuals > 0 > income Statement > eps
-263.4975848425467
Annuals > 0 > income Statement > dividends Per Share
277119000
Annuals > 0 > income Statement > shares Outstanding
80119
Annuals > 0 > income Statement > income Tax Expense
-21367170837
Annuals > 0 > income Statement > EBITDA
-21104470
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
63004
Annuals > 0 > balance Sheet > cash
1601660
Annuals > 0 > balance Sheet > short Term Investments
1600058340
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
2077467
Annuals > 0 > balance Sheet > property Plant Equipment
0
Annuals > 0 > balance Sheet > total Assets
4124325
Annuals > 0 > balance Sheet > payables
1074295
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2504170
Annuals > 0 > balance Sheet > equity
1620155
Annuals > 0 > cash Flow > net Income
-21111163
Annuals > 0 > cash Flow > depreciation
6693
Annuals > 0 > cash Flow > change In Working Capital
-121078
Annuals > 0 > cash Flow > cash From Operations
-17149088
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
1166
Annuals > 0 > cash Flow > cash From Financing
12011953
Annuals > 0 > cash Flow > net Change In Cash
-5135969
Annuals > 0 > ratios > PE
-263.4975848425467
Annuals > 0 > ratios > PB
0.1463762664683317
Annuals > 0 > ratios > ROE
-1303.033536914678
Annuals > 0 > ratios > ROA
-511.86953016554224
Annuals > 0 > ratios > FCF
-17149088
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
15004
Annuals > 1 > income Statement > gross Profit
-15004
Annuals > 1 > income Statement > operating Expenses
31060566
Annuals > 1 > income Statement > operating Income
-31075570
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-30860461
Annuals > 1 > income Statement > net Income
-30860461
Annuals > 1 > income Statement > eps
-1128.1469932370683
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
27355
Annuals > 1 > income Statement > income Tax Expense
-4
Annuals > 1 > income Statement > EBITDA
-31060566
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
215109
Annuals > 1 > balance Sheet > cash
6737629
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
0
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
7531767
Annuals > 1 > balance Sheet > property Plant Equipment
7859
Annuals > 1 > balance Sheet > total Assets
10670592
Annuals > 1 > balance Sheet > payables
1397610
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
3254208
Annuals > 1 > balance Sheet > equity
7416384
Annuals > 1 > cash Flow > net Income
-30860461
Annuals > 1 > cash Flow > depreciation
15004
Annuals > 1 > cash Flow > change In Working Capital
698126
Annuals > 1 > cash Flow > cash From Operations
-24738603
Annuals > 1 > cash Flow > capital Expenditures
71383
Annuals > 1 > cash Flow > cash From Investing
-71214
Annuals > 1 > cash Flow > cash From Financing
10593377
Annuals > 1 > cash Flow > net Change In Cash
-14216440
Annuals > 1 > ratios > PE
-1128.1469932370683
Annuals > 1 > ratios > PB
0.010917827340116154
Annuals > 1 > ratios > ROE
-416.11196237951003
Annuals > 1 > ratios > ROA
-289.2103924505782
Annuals > 1 > ratios > FCF
-24809986
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
25575
Annuals > 2 > income Statement > gross Profit
-25575
Annuals > 2 > income Statement > operating Expenses
23805144
Annuals > 2 > income Statement > operating Income
-23830719
Annuals > 2 > income Statement > interest Expense
18108235
Annuals > 2 > income Statement > pretax Income
-23740621
Annuals > 2 > income Statement > net Income
-23740621
Annuals > 2 > income Statement > eps
-990.1414272010677
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
23977
Annuals > 2 > income Statement > income Tax Expense
5722484
Annuals > 2 > income Statement > EBITDA
-23715046
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
90098
Annuals > 2 > balance Sheet > cash
20954069
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
34852
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
21473145
Annuals > 2 > balance Sheet > property Plant Equipment
23032
Annuals > 2 > balance Sheet > total Assets
25085027
Annuals > 2 > balance Sheet > payables
442925
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2810287
Annuals > 2 > balance Sheet > equity
22274740
Annuals > 2 > cash Flow > net Income
-23740621
Annuals > 2 > cash Flow > depreciation
25575
Annuals > 2 > cash Flow > change In Working Capital
1204138
Annuals > 2 > cash Flow > cash From Operations
-17778964
Annuals > 2 > cash Flow > capital Expenditures
4
Annuals > 2 > cash Flow > cash From Investing
97731
Annuals > 2 > cash Flow > cash From Financing
6426
Annuals > 2 > cash Flow > net Change In Cash
-17674807
Annuals > 2 > ratios > PE
-990.1414272010677
Annuals > 2 > ratios > PB
0.003186206438324308
Annuals > 2 > ratios > ROE
-106.58091183106964
Annuals > 2 > ratios > ROA
-94.64060373544744
Annuals > 2 > ratios > FCF
-17778968
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
22534
Annuals > 3 > income Statement > gross Profit
-22534
Annuals > 3 > income Statement > operating Expenses
20647568
Annuals > 3 > income Statement > operating Income
-20670102
Annuals > 3 > income Statement > interest Expense
5133
Annuals > 3 > income Statement > pretax Income
-20664969
Annuals > 3 > income Statement > net Income
-20664969
Annuals > 3 > income Statement > eps
-877.5306382436621
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
23549
Annuals > 3 > income Statement > income Tax Expense
-5133
Annuals > 3 > income Statement > EBITDA
-20642435
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
5133
Annuals > 3 > balance Sheet > cash
38628876
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
0
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
39140224
Annuals > 3 > balance Sheet > property Plant Equipment
48608
Annuals > 3 > balance Sheet > total Assets
42862286
Annuals > 3 > balance Sheet > payables
973195
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1585295
Annuals > 3 > balance Sheet > equity
41276991
Annuals > 3 > cash Flow > net Income
-19590491
Annuals > 3 > cash Flow > depreciation
22534
Annuals > 3 > cash Flow > change In Working Capital
1009952
Annuals > 3 > cash Flow > cash From Operations
-14284924
Annuals > 3 > cash Flow > capital Expenditures
83796
Annuals > 3 > cash Flow > cash From Investing
-83796
Annuals > 3 > cash Flow > cash From Financing
25677911
Annuals > 3 > cash Flow > net Change In Cash
11309191
Annuals > 3 > ratios > PE
-877.5306382436621
Annuals > 3 > ratios > PB
0.001688714179771486
Annuals > 3 > ratios > ROE
-50.06413621574305
Annuals > 3 > ratios > ROA
-48.21247518156171
Annuals > 3 > ratios > FCF
-14368720
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
0.0974
Valuation > metrics > PB
2.372312755939969
Valuation > final Score
100
Valuation > verdict
49.5% Undervalued
Profitability > metrics > ROE
-494.81705689059885
Profitability > metrics > ROA
-221.51698354790764
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
3.6398548072627626
Risk > metrics > Interest Coverage
-7.3447927665300545
Risk > final Score
-23
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.0590664955793525
Liquidity > metrics > Quick Ratio
1.0590664955793525
Liquidity > final Score
76
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
0
Prev Profitabilities > 2
15
Prev Risks > 0
-2691
Prev Risks > 1
-5213
Prev Risks > 2
-31792
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
98
Updated At
2025-12-16T22:44:02.069Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-14
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-5
Earnings History > 0 > eps Estimate
-0.65
Earnings History > 0 > eps Difference
-4.35
Earnings History > 0 > surprise Percent
-669.2308
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-8.47
Earnings History > 1 > eps Estimate
-0.74
Earnings History > 1 > eps Difference
-7.73
Earnings History > 1 > surprise Percent
-1044.5946
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-13
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.26
Earnings History > 2 > eps Estimate
-2.54
Earnings History > 2 > eps Difference
2.28
Earnings History > 2 > surprise Percent
89.7638
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.4242
Earnings History > 3 > eps Estimate
-0.39
Earnings History > 3 > eps Difference
-0.0342
Earnings History > 3 > surprise Percent
-8.7692
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-12
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.23
Earnings History > 4 > eps Estimate
-1.93
Earnings History > 4 > eps Difference
0.7
Earnings History > 4 > surprise Percent
36.2694
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-09
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-3
Earnings History > 5 > eps Estimate
-2.3
Earnings History > 5 > eps Difference
-0.7
Earnings History > 5 > surprise Percent
-30.4348
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-15
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-3.69
Earnings History > 6 > eps Estimate
-2.54
Earnings History > 6 > eps Difference
-1.15
Earnings History > 6 > surprise Percent
-45.2756
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-26
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-3.96
Earnings History > 7 > eps Estimate
-3.93
Earnings History > 7 > eps Difference
-0.03
Earnings History > 7 > surprise Percent
-0.7634
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.13
Earnings History > 8 > eps Estimate
-0.11
Earnings History > 8 > eps Difference
-0.02
Earnings History > 8 > surprise Percent
-18.1818
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-21
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.15
Earnings History > 9 > eps Estimate
-0.12
Earnings History > 9 > eps Difference
-0.03
Earnings History > 9 > surprise Percent
-25
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-22
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.19
Earnings History > 10 > eps Estimate
-0.12
Earnings History > 10 > eps Difference
-0.07
Earnings History > 10 > surprise Percent
-58.3333
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.13
Earnings History > 11 > eps Estimate
-0.15
Earnings History > 11 > eps Difference
0.02
Earnings History > 11 > surprise Percent
13.3333
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.13
Earnings History > 12 > eps Estimate
-0.12
Earnings History > 12 > eps Difference
-0.01
Earnings History > 12 > surprise Percent
-8.3333
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.11
Earnings History > 13 > eps Estimate
-0.12
Earnings History > 13 > eps Difference
0.01
Earnings History > 13 > surprise Percent
8.3333
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-13
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.12
Earnings History > 14 > eps Estimate
-0.12
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-30
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.12
Earnings History > 15 > eps Estimate
-0.09
Earnings History > 15 > eps Difference
-0.03
Earnings History > 15 > surprise Percent
-33.3333
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-15
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.07
Earnings History > 16 > eps Estimate
-0.11
Earnings History > 16 > eps Difference
0.04
Earnings History > 16 > surprise Percent
36.3636
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-13
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.08
Earnings History > 17 > eps Estimate
-0.13
Earnings History > 17 > eps Difference
0.05
Earnings History > 17 > surprise Percent
38.4615
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-17
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.14
Earnings History > 18 > eps Estimate
-0.12
Earnings History > 18 > eps Difference
-0.02
Earnings History > 18 > surprise Percent
-16.6667
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-26
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.14
Earnings History > 19 > eps Estimate
-0.28
Earnings History > 19 > eps Difference
0.14
Earnings History > 19 > surprise Percent
50
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-12
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.07
Earnings History > 20 > eps Estimate
-0.21
Earnings History > 20 > eps Difference
0.14
Earnings History > 20 > surprise Percent
66.6667
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-11
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.12
Earnings History > 21 > eps Estimate
-0.13
Earnings History > 21 > eps Difference
0.01
Earnings History > 21 > surprise Percent
7.6923
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-14
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.2
Earnings History > 22 > eps Estimate
-0.08
Earnings History > 22 > eps Difference
-0.12
Earnings History > 22 > surprise Percent
-150
Earnings History > 23 > period
2019-09-30
Earnings History > 23 > report Date
2019-11-14
Earnings History > 23 > date
2019-09-30
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.15
Earnings History > 23 > eps Estimate
-0.22
Earnings History > 23 > eps Difference
0.07
Earnings History > 23 > surprise Percent
31.8182
Earnings History > 24 > period
2019-06-30
Earnings History > 24 > report Date
2019-08-13
Earnings History > 24 > date
2019-06-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.24
Earnings History > 24 > eps Estimate
-0.21
Earnings History > 24 > eps Difference
-0.03
Earnings History > 24 > surprise Percent
-14.2857
Earnings History > 25 > period
2019-03-31
Earnings History > 25 > report Date
2019-05-15
Earnings History > 25 > date
2019-03-31
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.14
Earnings History > 25 > eps Estimate
-0.2
Earnings History > 25 > eps Difference
0.06
Earnings History > 25 > surprise Percent
30
Earnings History > 26 > period
2018-12-31
Earnings History > 26 > report Date
2019-03-29
Earnings History > 26 > date
2018-12-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-8
Earnings History > 26 > eps Estimate
-0.14
Earnings History > 26 > eps Difference
-7.86
Earnings History > 26 > surprise Percent
-5614.2857
Earnings History > 27 > period
2018-09-30
Earnings History > 27 > report Date
2018-11-14
Earnings History > 27 > date
2018-09-30
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.15
Earnings History > 27 > eps Estimate
-0.13
Earnings History > 27 > eps Difference
-0.02
Earnings History > 27 > surprise Percent
-15.3846
Earnings History > 28 > period
2018-06-30
Earnings History > 28 > report Date
2018-08-14
Earnings History > 28 > date
2018-06-30
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.31
Earnings History > 28 > eps Estimate
-0.17
Earnings History > 28 > eps Difference
-0.14
Earnings History > 28 > surprise Percent
-82.3529
Earnings History > 29 > period
2018-03-31
Earnings History > 29 > report Date
2018-05-15
Earnings History > 29 > date
2018-03-31
Earnings History > 29 > before After Market
AfterMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.05
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2017-09-30
Earnings History > 30 > report Date
2017-10-10
Earnings History > 30 > date
2017-09-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.07
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
-0.07
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2017-06-30
Earnings History > 31 > report Date
2017-07-21
Earnings History > 31 > date
2017-06-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.05
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.05
Earnings History > 31 > surprise Percent
-
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC. Its three-lung cancer clinical programs have received a Fast Track Designation from the FDA for the treatment of that patient population, and SCLC program has received an FDA Orphan Drug Designation. The company's diabetes gene therapy comprises of a novel infusion process that uses an AAV vector to deliver Pdx1 and MafA genes directly to the pancreas. In models of Type 1 diabetes, its GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which produce insulin but distinct enough from beta cells to evade the body's immune system; and GPX-002 for Type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. It has research agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive. Genprex, Inc. was incorporated in 2009 and is based in Austin, Texas.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACongressman Buys Shares Of Small Cap Lift Truck Company You've Probably Never Heard Of - Benzinga
12/4/2025
Congressman Buys Shares Of Small Cap Lift Truck Company You've Probably Never Heard Of Benzinga
Read more →Genprex, Inc. Stock (GNPX) Opinions on Recent Preclinical Data Release - Quiver Quantitative
12/3/2025
Genprex, Inc. Stock (GNPX) Opinions on Recent Preclinical Data Release Quiver Quantitative
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$7.5
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 3.40% of the total shares of Genprex Inc
1.
Susquehanna International Group, LLP(0.9095%)
since
2025/06/30
2.
Vanguard Institutional Extnd Mkt Idx Tr(0.8889%)
since
2025/07/31
3.
UBS Group AG(0.3921%)
since
2025/06/30
4.
Fidelity Extended Market Index(0.387%)
since
2025/07/31
5.
Geode Capital Management, LLC(0.2247%)
since
2025/06/30
6.
Virtu Financial LLC(0.1288%)
since
2025/06/30
7.
TWO SIGMA SECURITIES, LLC(0.0644%)
since
2025/06/30
8.
Fidelity Series Total Market Index(0.0502%)
since
2025/07/31
9.
Eqis Capital Management Inc(0.0495%)
since
2025/06/30
10.
TCG Advisory Services, LLC(0.0463%)
since
2025/06/30
11.
Vanguard Group Inc(0.0458%)
since
2025/06/30
12.
Spartan Total Market Index Pool G(0.045%)
since
2025/07/31
13.
HighTower Advisors, LLC(0.0418%)
since
2025/06/30
14.
Citigroup Inc(0.0377%)
since
2025/06/30
15.
BlackRock Inc(0.0283%)
since
2025/06/30
16.
Tower Research Capital LLC(0.0179%)
since
2025/06/30
17.
SBI Securities Co Ltd(0.0072%)
since
2025/06/30
18.
Fidelity Total Market Index(0.0051%)
since
2025/07/31
19.
EC SICAV EverCapital Invms UCITS I Ins I(0.0045%)
since
2025/07/31
20.
NT Ext Equity Mkt Idx Fd - NL(0.003%)
since
2025/06/30
21.
Morgan Stanley - Brokerage Accounts(0.0029%)
since
2025/06/30
22.
NT Ext Equity Mkt Idx Fd - L(0.0027%)
since
2025/06/30
23.
Northern Trust Extended Eq Market Idx(0.0027%)
since
2025/06/30
24.
Spartan Extended Market Index Pool F(0.0027%)
since
2025/07/31
25.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0023%)
since
2025/06/30
26.
Bank of America Corp(0.002%)
since
2025/06/30
27.
State St US Extended Mkt Indx NL Cl C(0.0012%)
since
2025/08/31
28.
Vanguard U.S. Eq Idx £ Acc(0.001%)
since
2025/07/31
29.
BNYM Mellon SL Market Completion UC1(0.001%)
since
2025/06/30
30.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0008%)
since
2025/06/30
31.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0007%)
since
2024/12/31
32.
SSgA U.S. Total Market Index Strategy(0.0005%)
since
2025/03/31
33.
Hanson Mcclain Inc(0.0004%)
since
2025/06/30
34.
State St US Ttl Mkt Indx NL Cl A(0.0004%)
since
2025/08/31
35.
Northern Trust Wilshire 5000(0.0004%)
since
2025/06/30
36.
Advisor Group Holdings, Inc.(0.0003%)
since
2025/06/30
37.
Royal Bank of Canada(0.0002%)
since
2025/06/30
38.
Mount Yale Investment Advisors, LLC(0.0001%)
since
2025/06/30
39.
FMR Inc(0.0001%)
since
2025/06/30
40.
Fidelity U.S. Equity Index Ins Trust(0%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-5
EPS Estimate
-0.65
EPS Difference
-4.35
Surprise Percent
-669.2308%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.